Scientist, Computational Biology
About the role
Visterra is seeking a Scientist to join our Genomics Platform team, which directly supports target identification, indication prioritization and supporting progression of drug candidates in clinical development. The team uses single-cell multi-omics, spatial transcriptomics, and human genetics to characterize human disease in kidney, autoimmune, and neurodegenerative indications. The Scientist will own projects end to end, from initial QC to biological interpretations and insights. This involves framing the question with program teams, shaping experimental designs for omics data generation, analyzing internally generated and public human datasets, and presenting the answer to stakeholders, including collaborating teams and senior management. This is a full-time position located at Visterra's offices in Waltham, MA.
About the team
The Genomics Platform team is composed of six researchers, three computational biologists and three experimental researchers. The two subgroups work as one team, designing experiments together and analyzing results together, so computational scientists shape what data gets generated rather than receive it afterward. The team focuses mostly on human data, generating paired single-cell and spatial transcriptomics data from human tissue in-house and combining them with public disease atlases and population genetics resources. They are members of the FNIH Accelerating Medicines Partnership in Autoimmune and Immune-Mediated Diseases (AMP AIM), which adds disease-tissue single-cell and spatial data in rheumatoid arthritis, lupus, Sjögren's disease, systemic sclerosis, and psoriatic disease. On the genetics side, the team has built an internal platform that moves from GWAS summary statistics to prioritized target genes through fine-mapping, colocalization, gene-level association, and single-cell integration. The team works in AWS and treats agentic AI as a core part of how a small team covers a lot of ground. Every computational scientist runs analyses with Claude Code, and the team is actively building agentic workflows that take a project from data acquisition through analysis to target reasoning. The team also maintains several academic collaborations and aims to publish.
Impact
- Find new targets: Analyze human disease tissue, including AMP AIM datasets across autoimmune diseases, to identify pathogenic cell states and the molecules that hold them in place, then partner with a discovery team as they develop biologics against the target you proposed.
- Decide where a drug goes: Integrate genetic, single-cell, and spatial evidence across diseases to prioritize indications for targets already in the pipeline.
- Explore new mechanisms of neurodegenerative diseases: Integrate genetic evidence across diseases and pathways, and explore immune mechanisms in neurodegenerative disease, as a source of new targets.
- Build the platform: Extend the internal genetics platform with new modules and tools, and help build the agentic workflows the team runs it with.
Responsibilities
- Own projects from question to recommendation: quality control, analysis, interpretation, and presentation.